Skip to content
Search
Please enter at least 3 characters.

Latest Stories

Alitam announces merger with clinical skills training provider MHRx to upskill its pharmacy teams

Alitam has announced that it has merged with clinical skills training provider MHRx to upskill UK pharmacists so that its chain of community pharmacies in the UK can diagnose and treat minor medical ailments “quickly and safely”.

This is a second merger deal announced by the group that has 100-plus pharmacies, just days after its merger with Pharmadoctor to "radically transform the UK and Ireland’s community pharmacy sector" into a truly preventative healthcare system.


Following the merger with MHRx, Alitam will now be providing a career development platform for its pharmacy teams, which also include nurses and other healthcare professionals.

MHRx’s training incorporates every aspect of general practice alongside relevant topics including making appropriate patient consultation records in line with NHS guidelines.

This, Alitam believes, will allow community pharmacies to carry out formal diagnoses, formulate differential diagnosis plans, and perform full clinical examinations.

According to the founder and CEO Feisal Nahaboo, mergers such as these will lead to "a healthcare revolution predicated on building the world’s first truly preventative healthcare model".

At the centre of this transformational, multi-billion-pound ‘Pharmacy of the Future’ project is Alitam’s effort to build a specialised group of pharmacies, rolling out medical and wellbeing services nationwide.

The company said: “Patients will be able to access a wide range of 60 clinical services including minor aliment walk-in clinics, men’s and women’s health checks, weight loss, a travel clinic, ear irrigation, hair loss treatment, aesthetics, and phlebotomy tests. Crucially, this will enable them to access urgent medical care without the need to wait for a GP or hospital appointment.”

Nahaboo said that redefining community pharmacists as the nation’s de facto front-line healthcare provider is essential to reducing NHS waiting lists for routine treatments, which currently stands at a record six million and is predicted to rise to eight to 10 million within a year.

Describing the old healthcare model as “a dying breed”, Nahaboo said: “I have a job on my hands to fundamentally help pharmacists see their future business in a very different way. The UK is a first-world country that should have a medical system built on prevention rather than cure.

“We are burdening the tax system by funding a national health system that is unnecessarily, and increasingly, becoming unwell due to a blockage of medical service support.

“The past model is a dying breed and pharmacists have a real opportunity now to rely less on NHS and HSE income and to focus on improving the nation’s health through examination and diagnosis services.

“I have the backing of thousands of pharmacies, and together we will realise our vision and play our part in improving our nation’s health.”

He added: “Pharmacy is changing. For me, it’s the number one industry to back because the scope of growth is huge. Losing reliance on dispensary is a big step, but one that will be highly rewarding for pharmacists and their communities in time to come. I understand that change unsettles people, and recognise that it will take some time to put infrastructure and personnel in place to best deliver medical services.

“However, the support teams from MHRx and Pharmadoctor makes this roll out that much easier. I’m looking forward to working with MHRx and Pharmadoctor, and will be adding additional partners via mergers, whilst I also plan to agree terms with a number of proactive and forward-thinking pharmacists looking to represent Alitam in their locality.”

More For You

Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less